EN
Home/Answers/Heart rate
ALLAll countries Side effects and safety

Do tirzepatide and semaglutide raise your heart rate?

What we checked10 sources, each one opened and linked to the sentence it supportsLast checked Nov 9, 2026 · Next review due Nov 9, 2027 ·How we write
The short answer

Yes. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) raise heart rate by a small average amount, 1 to 4 beats per minute on the US Wegovy label and 1 to 3 on the US Zepbound label. Some people have larger rises, and the US Wegovy label asks patients to report a racing heartbeat at rest.

How much do tirzepatide and semaglutide raise heart rate?

On average, both medicines raise heart rate by a few beats per minute, which the US labels put at 1 to 4 bpm.123

The US Wegovy label reports mean resting heart rate rises of 1 to 4 beats per minute (bpm) against placebo.1 The US Ozempic label gives 2 to 3 bpm, against a fall of 0.3 bpm on placebo.9

For tirzepatide, the US Zepbound label reports a mean rise of 1 to 3 bpm, and none on placebo.2 The US Mounjaro label gives 2 to 4 bpm, against 1 bpm on placebo.3 The UK Mounjaro SmPC (the official UK product information) gives 3 bpm in weight-management trials.6 It gives a maximum mean rise of 6 bpm in a heart-outcomes trial against another diabetes medicine (SURPASS-CVOT).6

MedlinePlus, from the US National Library of Medicine, lists a normal adult resting heart rate as 60 to 100 bpm.10

Can some people get a much bigger rise?

Yes, a minority have larger changes, and the US Wegovy label shows these were more common than on placebo.1

In adult Wegovy injection trials, 41% had a maximum change of 10 to 19 bpm, against 34% on placebo.1 A change of 20 bpm or more occurred in 26%, against 16%.1 These count each person's highest reading at any visit, not how long a rise lasted.1

The US Mounjaro label reports episodes of fast heart rate (sinus tachycardia) with a rise of 15 bpm or more. They occurred in 4.6%, 5.9% and 10% at 5, 10 and 15 mg, against 4.3% on placebo.3 Among patients in Japan, the 15 mg figure was 23% (10 of 43), against 7% (3 of 43) on placebo.3

Does the rise fade, or go away after stopping?

One trial on the US Zepbound label suggests the rise can shrink during treatment, and shrink further in people switched to placebo.2

In that trial, everyone took Zepbound for the first 36 weeks, and pulse rose 5.0 bpm.2 From week 36 to 88, it fell 2.1 bpm on continued Zepbound and 5.2 bpm on placebo.2 That took the placebo group back to about the 72.5 bpm the trial started from.2

For semaglutide, the heart-outcomes trial on the US Wegovy label still showed a rise of 3.8 bpm at week 104.1 The placebo group rose 0.7 bpm.1

We found no week-by-week timeline after stopping in the US Wegovy or Zepbound labels.

Is a faster heart rate on these medicines harmful?

The labels do not settle this, and the US Mounjaro label says the clinical relevance of heart rate increases is uncertain.3

In the UK Mounjaro SmPC's diabetes trials, heart rhythm and electrical conduction problems affected 3.8%, 2.1% and 3.7% on tirzepatide. On placebo it was 3%, and the SmPC reports no difference.6

The US Wegovy label's heart-outcomes trial enrolled adults with existing heart or artery disease. Heart attack, stroke or heart-related death occurred in 6.5% on Wegovy, against 8% on placebo.1 In that trial, 16% stopped Wegovy because of an adverse event, against 8% on placebo.1

That label tells prescribers to check heart rate regularly and stop Wegovy if a resting rise is sustained.1

A fast heartbeat can have other causes. The US Zepbound Medication Guide lists it as a symptom of low blood sugar.2

What do people on GLP-1 medicines report about heart rate?

From public patient forums: 183 Reddit threads in r/Zepbound, r/zepboundathletes, r/mounjarouk, r/Semaglutide, r/WegovyWeightLoss and r/Ozempic, read October 2025 to October 2026. Personal reports, not medical evidence.

What people describe

  • Matches the label Many describe a higher resting or overnight heart rate, often first seen on a wearable and most often up by 5 to 10 bpm. The US labels record a rise too, with smaller averages.12
  • Not studied Several say it peaked 1 to 3 days after the injection and eased before the next. We found no study of this weekly pattern.
  • Not studied Many say the rise eased within weeks to months, while several say it lasted many months or years. We found no study following this person by person.
  • Matches the label Many describe palpitations, skipped beats or fluttering. The US Wegovy label tells patients to report palpitations or a racing heartbeat at rest. It does not name skipped beats.1

Advice people share

  • Not studied Many suggest checking hydration and electrolytes. Some with heart conditions were told to ask a doctor first. We found no study showing this lowers heart rate on these medicines.
  • Matches the NHS Several suggest cutting or checking caffeine and alcohol. The NHS says avoiding triggers such as these can help palpitations when no health condition is the cause.8
  • Label says otherwise Several posts describe sub-label doses, split doses or stretched gaps between doses. The US Wegovy label says to inject once weekly on the same day, and the US Zepbound label sets once-weekly doses.12

In your country

Of the labels we could open, all record a small average rise, and only the US Wegovy label carries a heart rate warning.1234569

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: We could not open the Australian Product Information, so this page relies on the US and UK labels.

Emergency number: 000

GLP-1 side effects guide for Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: We could not open the Canadian product monographs, so this page relies on the US and UK labels.

Emergency number: 911

GLP-1 side effects guide for Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: We could not open the EU SmPCs, so this page relies on the US and UK labels.

Emergency number: 15 or 112

GLP-1 side effects guide for France (in French)

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open the EU SmPCs, so this page relies on the US and UK labels.

Emergency number: 112

GLP-1 side effects guide for Germany (in German)

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We could not open an Indian label, so this page relies on the US and UK labels.

Emergency number: 112

GLP-1 side effects guide for India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open a Saudi label, so this page relies on the US and UK labels.

Emergency number: 997 or 911

GLP-1 side effects guide for Saudi Arabia (in Arabic)

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open a UAE label, so this page relies on the US and UK labels.

Emergency number: 998 for an ambulance, or 999

GLP-1 side effects guide for the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: The UK Wegovy injection SmPC (the official UK product information) gives a mean rise of 3 bpm from 72 bpm.4 The UK Wegovy injection and Mounjaro SmPCs list the rise as a side effect. Neither has a heart rate warning like the US Wegovy label.46 The UK tablets SmPC gives 26.5% against 20.8% on placebo for rises of 20 bpm or more.5

Emergency number: 999

GLP-1 side effects guide for the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The Wegovy label has a heart rate warning. The Mounjaro and Zepbound labels report the rise under side effects only.123

Emergency number: 911

GLP-1 side effects guide for the US

Get help now: call your local emergency number Get emergency help for palpitations that do not go away, or palpitations with chest pain, shortness of breath, feeling dizzy or lightheaded, or fainting or feeling like you might faint.78 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if your heart has raced or pounded for several minutes and then settled,1 or if palpitations keep coming back, get worse or last longer than a few minutes but then stop.78 If emergency symptoms have come and gone, ask for an urgent appointment.7

Read the full picture

Related questions

Did this answer your question?

Sources

  1. US Wegovy (semaglutide) injection and tablets label, including Medication Guide, revised June 2026. DailyMed
  2. US Zepbound (tirzepatide) label and Medication Guide, revised August 2026. Eli Lilly
  3. US Mounjaro (tirzepatide) label, revised August 2026. Eli Lilly
  4. UK Wegovy FlexTouch (semaglutide injection) SmPC, updated on emc 22 September 2026. electronic Medicines Compendium
  5. UK Wegovy 25 mg tablets (semaglutide) SmPC, updated on emc 16 June 2026. electronic Medicines Compendium
  6. UK Mounjaro KwikPen (tirzepatide) SmPC, updated on emc 8 September 2026. electronic Medicines Compendium
  7. NHS, Heart rhythm problems (arrhythmia). nhs.uk
  8. NHS, Heart palpitations. nhs.uk
  9. US Ozempic (semaglutide) injection label, revised May 2026. DailyMed
  10. MedlinePlus (US National Library of Medicine), Pulse. medlineplus.gov

Last checked Nov 9, 2026 · Next review due Nov 9, 2027 ·Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write